01
Growth leader
Romania → Netherlands
+3,349.2%3-year CAGR
$931.7K latest value · 3.2% share
Route intelligence
The routes that move Medicaments: containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)
A sharper view of the exporter-to-importer lanes behind the product. Start with the routes that matter most, then compare growth, access, and emerging signals.
Leading corridorItaly → USA, Puerto Rico and US Virgin Islands$241.6M latest reported trade
Top five concentration451.8%share of the displayed product total
Latest reported year2024100 tracked route records
Market pulseReported movementproduct-level direction
Growth lanes69corridors with positive 3-year growth
Access coverage44routes with reported FTA context
View statusReportedderived route comparison
The corridor workbench
Where the product actually moves
Ranked by the latest reported trade value. Use growth and access together; a large lane is not automatically an easy lane.
Top 100 corridorsLatest reported value
| Rank | Route | Trade value | 3-year growth | Share | Access | Signal |
|---|---|---|---|---|---|---|
| 01 | Italy → USA, Puerto Rico and US Virgin IslandsITA / USA | $241.6M | +39% | 88.5% | No FTA reported | Accelerating |
| 02 | Italy → Switzerland, LiechtensteinITA / CHE | $117.2M | +12.9% | 98.2% | FTA reported | Accelerating |
| 03 | China → IndiaCHN / IND | $39.4M | -7.3% | 98.3% | No FTA reported | Growing |
| 04 | China → BrazilCHN / BRA | $38.7M | +14.8% | 95.5% | No FTA reported | Growing |
| 05 | Jordan → United Arab EmiratesJOR / ARE | $22.0M | +339.1% | 71.3% | FTA reported | Growing |
| 06 | United Kingdom → USA, Puerto Rico and US Virgin IslandsGBR / USA | $18.6M | +62.7% | 6.8% | No FTA reported | Stable |
| 07 | China → GermanyCHN / DEU | $17.9M | -3.3% | 43.6% | No FTA reported | Growing |
| 08 | China → MexicoCHN / MEX | $16.6M | +22.5% | 75.2% | No FTA reported | Accelerating |
| 09 | China → PakistanCHN / PAK | $16.5M | +0.9% | 94.1% | FTA reported | Accelerating |
| 10 | China → Republic of KoreaCHN / KOR | $15.4M | +28.6% | 64.1% | FTA reported | Accelerating |
| 11 | China → RussiaCHN / RUS | $15.2M | +24.8% | 69.6% | No FTA reported | Accelerating |
| 12 | China → SpainCHN / ESP | $14.6M | +77.2% | 87.3% | No FTA reported | Accelerating |
| 13 | Netherlands → ItalyNLD / ITA | $13.2M | +87.3% | 50.8% | FTA reported | Accelerating |
| 14 | China → Viet NamCHN / VNM | $12.9M | +25.7% | 66% | FTA reported | Accelerating |
| 15 | China → PhilippinesCHN / PHL | $11.9M | +48.7% | 86.7% | FTA reported | Accelerating |
| 16 | Thailand → CambodiaTHA / KHM | $11.6M | +3.4% | 96.6% | FTA reported | Accelerating |
| 17 | China → EgyptCHN / EGY | $11.6M | +10.1% | 90.9% | No FTA reported | Accelerating |
| 18 | China → TurkeyCHN / TUR | $11.2M | -18% | 70.9% | No FTA reported | Growing |
| 19 | Japan → NetherlandsJPN / NLD | $10.8M | +94.1% | 37.1% | FTA reported | Stable |
| 20 | China → IndonesiaCHN / IDN | $10.2M | -18.4% | 79.8% | FTA reported | Growing |
| 21 | Saudi Arabia → EgyptSAU / EGY | $9.5M | -15.3% | 50.9% | FTA reported | Growing |
| 22 | China → ColombiaCHN / COL | $9.5M | +7.1% | 85.9% | No FTA reported | Accelerating |
| 23 | China → ArgentinaCHN / ARG | $9.4M | +11.9% | 79.6% | No FTA reported | Accelerating |
| 24 | Netherlands → GermanyNLD / DEU | $9.3M | +13.4% | 22.5% | FTA reported | Accelerating |
| 25 | USA, Puerto Rico and US Virgin Islands → NetherlandsUSA / NLD | $8.1M | +25.7% | 28% | No FTA reported | Growing |
Movement to watch
Growth leaders and emerging lanes
The strongest growth rates are a starting point for investigation, not a forecast. Check the underlying value and route conditions.
02
Growth leader
Indonesia → India
+1,005.5%3-year CAGR
$3.6M latest value · 7.6% share
03
Growth leader
Brazil → Canada
+986%3-year CAGR
$692.5K latest value · 6.4% share
04
Growth leader
New Zealand → Canada
+795.6%3-year CAGR
$790.5K latest value · 5.2% share
Emerging signals
Routes changing shape
These corridors carry a reported signal or a non-routine attention label in the available route context.
AcceleratingItaly → USA, Puerto Rico and US Virgin Islands+39%
AcceleratingItaly → Switzerland, Liechtenstein+12.9%
GrowingChina → India-7.3%
GrowingChina → Brazil+14.8%
Access comparison
Does preferential access show up in the route mix?
Compare the value and growth of corridors with a reported free-trade agreement indicator against corridors without one. This is context for research, not a tariff recommendation.
Read the methodology ↗FTA reported$333.3M
44 corridors · +87.9% average growthNo FTA reported$540.4M
56 corridors · +109.7% average growthAccess fields are shown only where reported context is available.
How to read this view
Scale, momentum, and access belong in the same frame.
Trade value identifies the routes with the largest observed footprint. Growth shows how that footprint has changed over the available three-year comparison. Share indicates the route's position within the displayed product view.
Distance, FTA status, volatility, and signals add context from supporting bilateral datasets. Missing values are not filled or treated as zero.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-27). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.